Jingya Qiu

Statistics

Publications

Citations

924

H-Index

Active since

2019

Affiliations

University of Pennsylvania(Current)

Parker Institute for Cancer Immunotherapy

Translational Therapeutics (United States)

Cancer Research Institute

Cornell University

Jingya Qiu is an author at University of Pennsylvania specializing in checkpoint inhibitor therapy, immune checkpoint blockade resistance, and cancer immunotherapy.

Publications per year

2019–2024

Publications

Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade

Joseph L. Benci, Lexus R. Johnson, Ruth Choa et al. · Cell · 2019 · 553 citations · Full text

Life Sciences, Immunology, Oncology +16

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

Danish Memon, Adam J. Schoenfeld, Darwin Ye et al. · Cancer Cell · 2024 · 178 citations · Full text

Medicine, Immunology, Oncology +17

Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction

Jingya Qiu, Bihui Xu, Darwin Ye et al. · Nature Cancer · 2023 · 102 citations

Medicine, Cancer Biology, Oncology +17

The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade

Lisa Cucolo, Qingzhou Chen, Jingya Qiu et al. · Immunity · 2022 · 91 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–4 of 4